비뇨기 보충제 시장 : 유형별, 용도별, 제제별, 유통 채널별, 예측(2024-2032년)

Urology supplements market size is set to register a 7.4% CAGR during 2024-2032, driven by the increasing prevalence of urological conditions and the rising awareness of preventive healthcare. With the aging global population ages and evolving lifestyles, urological disorders, such as urinary tract infections, kidney stones, and prostate conditions have become more prevalent.

As per reports, urinary tract infections are globally prevalent, affecting 150 million people worldwide every year. Rising advancements in nutritional science and research have identified specific ingredients, such as saw palmetto, cranberry extract, and beta-sitosterol, known for their beneficial effects on urinary and prostate health.

Increasing consumer awareness about the importance of proactive health management and preventive measures against urological issues is also fueling the market growth. Urology supplements are perceived as natural and non-invasive alternatives to traditional pharmaceutical treatments, appealing to individuals seeking complementary therapies to support their urological health. The rise of e-commerce platforms and direct-to-consumer marketing strategies will also contribute to the market expansion.

The urology supplements industry is segmented into type, application, formulation, distribution channel and region.

Based on application, the market size from the kidney health segment is poised to generate substantial revenue by 2032 due to the increasing prevalence of kidney-related disorders and the rising awareness of kidney health maintenance. Urology supplements formulated with ingredients like cranberry extract, dandelion root, and vitamin B6 are gaining popularity for their purported benefits in supporting kidney function and urinary tract health.

Urology supplements industry from the tablets formulation segment is set to grow over the forecast period, led by its convenience, ease of consumption, and formulation versatility. Urology supplements in tablet form offer consumers a convenient way to incorporate essential nutrients and herbal extracts known for their urological benefits into their daily health routines. Tablets are also preferred for their portability, longer shelf life, and precise dosing, which appeals to consumers looking for straightforward and consistent supplementation.

Asia Pacific urology supplements industry will grow significantly through 2032, attributed to the increasing aging population across Japan, China, and South Korea, which is prone to age-related urological conditions, such as benign prostatic hyperplasia (BPH) and urinary tract infections. The growing prevalence of lifestyle-related factors like sedentary lifestyles, unhealthy diets, and stress will also contribute to the rise in urological disorders, prompting individuals to seek preventive measures and complementary therapies in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of urological disorders
    • 3.2.1.2 Advancements in product formulations and delivery systems
    • 3.2.1.3 Increasing emphasis on preventive healthcare
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Potential interactions and side effects
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Multi-ingredient
• 5.3 Single ingredient

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Urinary tract infections
• 6.3 Kidney health
• 6.4 Prostate health
• 6.5 Bladder health
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Formulation, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Capsules
• 7.3 Softgels
• 7.4 Tablets
• 7.5 Liquid
• 7.6 Other formulations

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Brick & mortar
• 8.3 E-commerce

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Amway
• 10.2 Biotexlife
• 10.3 Himalaya Wellness
• 10.4 Himalayan Organics
• 10.5 Natrol, LLC
• 10.6 Nature's Bounty
• 10.7 Puritan's Pride
• 10.8 Solaray
• 10.9 Theralogix
• 10.10 ZAHLER